270 related articles for article (PubMed ID: 2287556)
1. Risk of nephrotoxicity with combination vancomycin-aminoglycoside antibiotic therapy.
Pauly DJ; Musa DM; Lestico MR; Lindstrom MJ; Hetsko CM
Pharmacotherapy; 1990; 10(6):378-82. PubMed ID: 2287556
[TBL] [Abstract][Full Text] [Related]
2. Mild nephrotoxicity associated with vancomycin use.
Downs NJ; Neihart RE; Dolezal JM; Hodges GR
Arch Intern Med; 1989 Aug; 149(8):1777-81. PubMed ID: 2764651
[TBL] [Abstract][Full Text] [Related]
3. Incidence of nephrotoxicity and association with vancomycin use in intensive care unit patients with pneumonia: retrospective analysis of the IMPACT-HAP Database.
Cano EL; Haque NZ; Welch VL; Cely CM; Peyrani P; Scerpella EG; Ford KD; Zervos MJ; Ramirez JA; Kett DH;
Clin Ther; 2012 Jan; 34(1):149-57. PubMed ID: 22284995
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for nephrotoxicity associated with continuous vancomycin infusion in outpatient parenteral antibiotic therapy.
Ingram PR; Lye DC; Tambyah PA; Goh WP; Tam VH; Fisher DA
J Antimicrob Chemother; 2008 Jul; 62(1):168-71. PubMed ID: 18334494
[TBL] [Abstract][Full Text] [Related]
5. A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia.
Jeffres MN; Isakow W; Doherty JA; Micek ST; Kollef MH
Clin Ther; 2007 Jun; 29(6):1107-15. PubMed ID: 17692725
[TBL] [Abstract][Full Text] [Related]
6. The Relationship of nephrotoxicity to vancomycin trough serum concentrations in a veteran's population: a retrospective analysis.
Horey A; Mergenhagen KA; Mattappallil A
Ann Pharmacother; 2012 Nov; 46(11):1477-83. PubMed ID: 23073306
[TBL] [Abstract][Full Text] [Related]
7. Increasing vancomycin serum trough concentrations and incidence of nephrotoxicity.
Pritchard L; Baker C; Leggett J; Sehdev P; Brown A; Bayley KB
Am J Med; 2010 Dec; 123(12):1143-9. PubMed ID: 21183005
[TBL] [Abstract][Full Text] [Related]
8. Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients.
Lodise TP; Patel N; Lomaestro BM; Rodvold KA; Drusano GL
Clin Infect Dis; 2009 Aug; 49(4):507-14. PubMed ID: 19586413
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness analysis of serum vancomycin concentration monitoring in patients with hematologic malignancies.
Fernández de Gatta MD; Calvo MV; Hernández JM; Caballero D; San Miguel JF; Domínguez-Gil A
Clin Pharmacol Ther; 1996 Sep; 60(3):332-40. PubMed ID: 8841156
[TBL] [Abstract][Full Text] [Related]
10. Nephrotoxicity due to combination antibiotic therapy with vancomycin and aminoglycosides in septic critically ill patients.
Malacarne P; Bergamasco S; Donadio C
Chemotherapy; 2006; 52(4):178-84. PubMed ID: 16691027
[TBL] [Abstract][Full Text] [Related]
11. Relationship of serum antibiotic concentrations to nephrotoxicity in cancer patients receiving concurrent aminoglycoside and vancomycin therapy.
Cimino MA; Rotstein C; Slaughter RL; Emrich LJ
Am J Med; 1987 Dec; 83(6):1091-7. PubMed ID: 3503577
[TBL] [Abstract][Full Text] [Related]
12. An audit of efficacy and toxicity of teicoplanin versus vancomycin in febrile neutropenia: is the different toxicity profile clinically relevant?
Hahn-Ast C; Glasmacher A; Arns A; Mühling A; Orlopp K; Marklein G; Von Lilienfeld-Toal M
Infection; 2008 Feb; 36(1):54-8. PubMed ID: 18193385
[TBL] [Abstract][Full Text] [Related]
13. Extended-interval aminoglycoside dosing for treatment of enterococcal and staphylococcal osteomyelitis.
Graham AC; Mercier RC; Achusim LE; Pai MP
Ann Pharmacother; 2004 Jun; 38(6):936-41. PubMed ID: 15084688
[TBL] [Abstract][Full Text] [Related]
14. Do vancomycin serum levels predict failures of vancomycin therapy or nephrotoxicity in cancer patients?
Kralovicová K; Spanik S; Halko J; Netriova J; Studena-Mrazova M; Novotny J; Grausova S; Koren P; Krupova I; Demitrovicova A; Kukuckova E; Krcmery V
J Chemother; 1997 Dec; 9(6):420-6. PubMed ID: 9491842
[TBL] [Abstract][Full Text] [Related]
15. Nephrotoxicity of vancomycin, alone and with an aminoglycoside.
Rybak MJ; Albrecht LM; Boike SC; Chandrasekar PH
J Antimicrob Chemother; 1990 Apr; 25(4):679-87. PubMed ID: 2351627
[TBL] [Abstract][Full Text] [Related]
16. Nephrotoxicity of continuous versus intermittent infusion of vancomycin in outpatient parenteral antimicrobial therapy.
Ingram PR; Lye DC; Fisher DA; Goh WP; Tam VH
Int J Antimicrob Agents; 2009 Dec; 34(6):570-4. PubMed ID: 19744837
[TBL] [Abstract][Full Text] [Related]
17. Lack of nephrotoxicity in pediatric patients receiving concurrent vancomycin and aminoglycoside therapy.
Nahata MC
Chemotherapy; 1987; 33(4):302-4. PubMed ID: 3608631
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology of vancomycin-induced neutropenia in patients receiving home intravenous infusion therapy.
Pai MP; Mercier RC; Koster SA
Ann Pharmacother; 2006 Feb; 40(2):224-8. PubMed ID: 16434560
[TBL] [Abstract][Full Text] [Related]
19. [Glycopeptides and the newborn infant's kidney].
Fanos V; Benini D; Vinco S; Pizzini C; Khoory BJ
Pediatr Med Chir; 1997; 19(4):259-62. PubMed ID: 9508651
[TBL] [Abstract][Full Text] [Related]
20. Nephrotoxicity of aminoglycosides and cephalosporins in combination.
Rankin GO; Sutherland CH
Adverse Drug React Acute Poisoning Rev; 1989; 8(2):73-88. PubMed ID: 2672726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]